Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1
- PMID: 21406612
- PMCID: PMC3605916
- DOI: 10.1152/ajpendo.00531.2010
Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1
Abstract
Increased dietary fat intake is associated with obesity, insulin resistance, and metabolic disease. In transgenic mice, adipose tissue-specific overexpression of the glucocorticoid-amplifying enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) exacerbates high-fat (HF) diet-induced visceral obesity and diabetes, whereas 11β-HSD1 gene knockout ameliorates this, favoring accumulation of fat in nonvisceral depots. Paradoxically, in normal mice HF diet-induced obesity (DIO) is associated with marked downregulation of adipose tissue 11β-HSD1 levels. To identify the specific dietary fats that regulate adipose 11β-HSD1 and thereby impact upon metabolic disease, we either fed mice diets enriched (45% calories as fat) in saturated (stearate), monounsaturated (oleate), or polyunsaturated (safflower oil) fats ad libitum or we pair fed them a low-fat (11%) control diet for 4 wk. Adipose and liver mass and glucocorticoid receptor and 11β-HSD1 mRNA and activity levels were determined. Stearate caused weight loss and hypoinsulinemia, partly due to malabsorption, and this markedly increased plasma corticosterone levels and adipose 11β-HSD1 activity. Oleate induced pronounced weight gain and hyperinsulinemia in association with markedly low plasma corticosterone and adipose 11β-HSD1 activity. Weight gain and hyperinsulinemia was less pronounced with safflower compared with oleate despite comparable suppression of plasma corticosterone and adipose 11β-HSD1. However, with pair feeding, safflower caused a selective reduction in visceral fat mass and relative insulin sensitization without affecting plasma corticosterone or adipose 11β-HSD1. The dynamic depot-selective relationship between adipose 11β-HSD1 and fat mass strongly implicates a dominant physiological role for local tissue glucocorticoid reactivation in fat mobilization.
Figures






Similar articles
-
11beta-hydroxysteroid dehydrogenase type 1 and obesity.Front Horm Res. 2008;36:146-164. doi: 10.1159/000115363. Front Horm Res. 2008. PMID: 18230901 Review.
-
Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue.Lipids Health Dis. 2010 Oct 8;9:111. doi: 10.1186/1476-511X-9-111. Lipids Health Dis. 2010. PMID: 20932307 Free PMC article.
-
Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.J Pharmacol Exp Ther. 2014 Apr;349(1):66-74. doi: 10.1124/jpet.113.210716. Epub 2014 Feb 7. J Pharmacol Exp Ther. 2014. PMID: 24511146
-
Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.J Mol Endocrinol. 2008 Aug;41(2):53-64. doi: 10.1677/JME-08-0004. Epub 2008 Jun 4. J Mol Endocrinol. 2008. PMID: 18524870 Free PMC article.
-
Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.Curr Drug Targets Immune Endocr Metabol Disord. 2003 Dec;3(4):255-62. doi: 10.2174/1568008033340135. Curr Drug Targets Immune Endocr Metabol Disord. 2003. PMID: 14683456 Review.
Cited by
-
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.Physiol Rev. 2013 Jul;93(3):1139-206. doi: 10.1152/physrev.00020.2012. Physiol Rev. 2013. PMID: 23899562 Free PMC article. Review.
-
Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.Am J Physiol Endocrinol Metab. 2013 May 15;304(10):E1035-41. doi: 10.1152/ajpendo.00029.2013. Epub 2013 Mar 19. Am J Physiol Endocrinol Metab. 2013. PMID: 23512810 Free PMC article.
-
Is 11β-HSD1 expressed in islet β-cells and regulated by corticotropin-releasing hormone?Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):E1390; author reply E1391. doi: 10.1073/pnas.1116146109. Epub 2011 Dec 9. Proc Natl Acad Sci U S A. 2011. PMID: 22159036 Free PMC article. No abstract available.
-
Decreased 11β-Hydroxysteroid Dehydrogenase 1 Level and Activity in Murine Pancreatic Islets Caused by Insulin-Like Growth Factor I Overexpression.PLoS One. 2015 Aug 25;10(8):e0136656. doi: 10.1371/journal.pone.0136656. eCollection 2015. PLoS One. 2015. PMID: 26305481 Free PMC article.
-
Effects of high fat feeding on liver gene expression in diabetic goto-kakizaki rats.Gene Regul Syst Bio. 2012;6:151-68. doi: 10.4137/GRSB.S10371. Epub 2012 Nov 28. Gene Regul Syst Bio. 2012. PMID: 23236253 Free PMC article.
References
-
- Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med. 1995;27:435–438. - PubMed
-
- Berthiaume M, Laplante M, Festuccia W, Gélinas Y, Poulin S, Lalonde J, Joanisse DR, Thieringer R, Deshaies Y. Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology. 2007;148:2391–2397. - PubMed
-
- Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 2008;7:95–96. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous